PEPTIDE COMPARISON

Selank vs DSIP

A small anxiety research program compared with historical sleep-peptide studies.

QUICK ANSWER

Selank vs DSIP: the main difference.

Selank has a small active-comparator human study base; DSIP relies on much older and smaller experiments. Neither establishes a modern standard treatment for anxiety or sleep disorders.

Decision field	Selank	DSIP
Human research	Small regional anxiety studies	Tiny historical sleep studies
Primary research	Anxiety and neuroimmune signaling	Sleep physiology and stress response
FDA status	Not approved; compounding concerns	Not approved
Main uncertainty	Independent comparative evidence	Identity, mechanism, and modern efficacy
Evidence confidence	Low	Very low

SOURCES

Selank vs DSIP sources.

Human trial / 2008Selank compared with medazepam in anxiety disordersPubMed Review / 2018Selank pharmacology and research reviewPubMed FDA / 2026Bulk substances that may present significant safety risksU.S. FDA Human trial / 1981Double-blind crossover study of DSIP in healthy volunteersPubMed Review / 1983Delta sleep-inducing peptide: human studies reviewPubMed Government / 2023Compounding pharmacy plea involving unlawful unapproved drug distributionU.S. Department of Justice

Selank vs DSIP: the main difference.

Selank vs DSIP sources.

Questions related to Selank vs DSIP.

Compare the next decision.